Utilization of Autologous HCT in Multiple Myeloma: A Novel Linkage of CIBMTR, Cancer Registry and Hospitalization Data in California
Naseem Esteghamat(University of California System), Theresa H.M. Keegan(UC Davis Comprehensive Cancer Center), Renata Abrahão(University of California Davis Medical Center), Ted Wun(VA Northern California Health Care System), Sara J. Schonfeld(National Cancer Institute), Bryan Valcárcel(Milken Institute), Lindsay M. Morton(National Cancer Institute), Ann Brunson(UC Davis Comprehensive Cancer Center), Christa L. Meyer(National Marrow Donor Program), Julianne J.P. Cooley(UC Davis Comprehensive Cancer Center), Jeffery J. Auletta(Nationwide Children's Hospital), Aaron S. Rosenberg(UC Davis Comprehensive Cancer Center), Lori Muffly(Stanford University)
Cited by 0
Related Papers
2016 US lymphoid malignancy statistics by World Health Organization subtypes
|CA A Cancer Journal for Clinicians|2016|1.1k
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830